These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 19557579)

  • 21. Oncological resource allocation in Germany.
    Hartmann M; Kath R; Gundermann C
    Onkologie; 2008 Mar; 31(3):85-9. PubMed ID: 18322410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost of cancer care: issues and implications.
    Meropol NJ; Schulman KA
    J Clin Oncol; 2007 Jan; 25(2):180-6. PubMed ID: 17210937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of endoscopic screening followed by surveillance for Barrett's esophagus: a review.
    Barbiere JM; Lyratzopoulos G
    Gastroenterology; 2009 Dec; 137(6):1869-76. PubMed ID: 19840798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of cancer staging in evidence-based medicine.
    Mackillop WJ; O'Sullivan B; Gospodarowicz M
    Cancer Prev Control; 1998 Dec; 2(6):269-77. PubMed ID: 10470456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evidence-based medicine in oncology: do the results of trials reflect clinical reality?].
    Hölzel D; Schubert-Fritschle G
    Zentralbl Chir; 2008 Feb; 133(1):15-9. PubMed ID: 18278696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative effectiveness research.
    Demaria AN
    J Am Coll Cardiol; 2009 Mar; 53(11):973-5. PubMed ID: 19281929
    [No Abstract]   [Full Text] [Related]  

  • 27. How should we pay the piper when he's calling the tune? On the long-term affordability of cancer care in the United States.
    Ramsey SD
    J Clin Oncol; 2007 Jan; 25(2):175-9. PubMed ID: 17210936
    [No Abstract]   [Full Text] [Related]  

  • 28. Cost-effectiveness, cancer burden and financial crisis: a perfect storm.
    Belda-Iniesta C
    Clin Transl Oncol; 2012 Oct; 14(10):713-4. PubMed ID: 22996423
    [No Abstract]   [Full Text] [Related]  

  • 29. Cost effectiveness, chemotherapy, and the clinician.
    Griggs JJ; Sorbero ME
    Breast Cancer Res Treat; 2009 Apr; 114(3):597-8. PubMed ID: 18695985
    [No Abstract]   [Full Text] [Related]  

  • 30. Enlightened oncologists can provide quality cancer care at reduced costs.
    Devi CR
    J Surg Oncol; 2014 Nov; 110(6):643-4. PubMed ID: 25125148
    [No Abstract]   [Full Text] [Related]  

  • 31. The oncology nurse practitioner: a unique provider for the follow-up for early-stage breast cancer.
    Rosenzweig MQ
    J Clin Oncol; 2006 Aug; 24(22):3710-1; author reply 3711-2. PubMed ID: 16877742
    [No Abstract]   [Full Text] [Related]  

  • 32. Complementary and alternative medicine: the role of the cancer center.
    Antman K; Benson MC; Chabot J; Cobrinik D; Grann VR; Jacobson JS; Joe AK; Katz AE; Kelly K; Neugut AI; Russo D; Tiersten A; Weinstein IB
    J Clin Oncol; 2001 Sep; 19(18 Suppl):55S-60S. PubMed ID: 11560974
    [No Abstract]   [Full Text] [Related]  

  • 33. Cancer care, money, and the value of life: whose justice? Which rationality?
    Sulmasy DP
    J Clin Oncol; 2007 Jan; 25(2):217-22. PubMed ID: 17210943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is high and growing spending on cancer treatment and prevention harmful to the United States economy?
    Pauly MV
    J Clin Oncol; 2007 Jan; 25(2):171-4. PubMed ID: 17210935
    [No Abstract]   [Full Text] [Related]  

  • 35. Cost of cancer care: the patient perspective.
    Kim P
    J Clin Oncol; 2007 Jan; 25(2):228-32. PubMed ID: 17210945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can we afford the war on cancer?
    Szucs TD
    Onkologie; 2008 Mar; 31(3):81. PubMed ID: 18322408
    [No Abstract]   [Full Text] [Related]  

  • 37. Personalized medicine and therapeutic decision-making in oncology: a commentary on key environmental issues.
    Freeman RA
    J Oncol Pharm Pract; 2011 Sep; 17(3):295-7. PubMed ID: 20551112
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment success in cancer.
    Korn EL; Mooney MM; Abrams JS
    Arch Intern Med; 2008 Oct; 168(19):2173; author reply 2173-4. PubMed ID: 18955658
    [No Abstract]   [Full Text] [Related]  

  • 39. Economic evaluation in radiology: reviewing the literature and examples in oncology.
    Bresnahan BW
    Acad Radiol; 2010 Sep; 17(9):1090-5. PubMed ID: 20634104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions between academic oncology and alternative/complementary/integrative medicine: complex but necessary.
    Markman M
    J Clin Oncol; 2001 Sep; 19(18 Suppl):52S-53S. PubMed ID: 11560972
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.